Clinical Trials Browser

Active not recruiting × Biliary Tract Neoplasms × Bevacizumab × Clear all

NCT06465563 2026-05-29

SHR-8068 in Combination With Adebrelimab, Bevacizumab, and Platinum-Based Chemotherapy as First-line Treatment in Patients With Advanced Biliary Tract Cancer

Phase 2 Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms